-
1
-
-
0035024272
-
Clinical variations and complications of Coats disease in 150 cases: The 2000 Sanford Gifford Memorial Lecture
-
DOI 10.1016/S0002-9394(00)00883-7, PII S0002939400008837
-
Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of Coats disease in 150 cases. The 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561-571 (Pubitemid 32422112)
-
(2001)
American Journal of Ophthalmology
, vol.131
, Issue.5
, pp. 561-571
-
-
Shields, J.A.1
Shields, C.L.2
Honavar, S.G.3
Demirci, H.4
-
2
-
-
0035003144
-
Classification and management of Coats disease: The 2000 Proctor Lecture
-
DOI 10.1016/S0002-9394(01)00896-0, PII S0002939401008960
-
Shields JA, Shields CL, Honavar SG, Demirci H, Cater J (2001) Classification and management of Coats disease. The 2000 proctor lecture. Am J Ophthalmol 131:572-583 (Pubitemid 32422113)
-
(2001)
American Journal of Ophthalmology
, vol.131
, Issue.5
, pp. 572-583
-
-
Shields, J.A.1
Shields, C.L.2
Honavar, S.G.3
Demirci, H.4
Cater, J.5
-
3
-
-
20144380604
-
Coats' disease diagnosed in adulthood
-
DOI 10.1016/j.ophtha.2004.12.038, PII S0161642005001168
-
Smithen LM, Brown GC, Brucker AJ, Yanuzzi LA, Klais CM, Spaide RF (2005) Coats' disease diagnosed in adulthood. Ophthalmology 112:1072-1078 (Pubitemid 40797464)
-
(2005)
Ophthalmology
, vol.112
, Issue.6
, pp. 1072-1078
-
-
Smithen, L.M.1
Brown, G.C.2
Brucker, A.J.3
Yannuzzi, L.A.4
Klais, C.M.5
Spaide, R.F.6
-
4
-
-
77952194133
-
Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: Effects and complications
-
Othman IS, Moussa M, Bouhaimed M (2010) Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol 94:606-610
-
(2010)
Br J Ophthalmol
, vol.94
, pp. 606-610
-
-
Othman, I.S.1
Moussa, M.2
Bouhaimed, M.3
-
5
-
-
33646229534
-
Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide
-
Jarin RR, Teoh SCB, Lim TH (2006) Resolution of severe macular oedema in adult Coat's syndrome with high-dose intravitreal triamcinolone acetonide. Eye 20:163e5
-
(2006)
Eye
, vol.20
-
-
Jarin, R.R.1
Teoh, S.C.B.2
Lim, T.H.3
-
6
-
-
45849136317
-
Coat's disease treated with bevacizumab (Avastin)
-
Spanish
-
Alvarez-Rivera LG, Abraham-Marín ML, Flores-Orta HJ, Mayorquín-Ruiz M, Cortés-Luna CF (2008) Coat's disease treated with bevacizumab (Avastin). Arch Soc Esp Oftalmol 83:329-331 Spanish
-
(2008)
Arch Soc Esp Oftalmol
, vol.83
, pp. 329-331
-
-
Alvarez-Rivera, L.G.1
Abraham-Marín, M.L.2
Flores-Orta, H.J.3
Mayorquín-Ruiz, M.4
Cortés-Luna, C.F.5
-
8
-
-
45449108608
-
Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease
-
DOI 10.1016/j.jaapos.2008.01.009, PII S1091853108000372
-
Cakir M, Cekic O, Yilmaz F (2008) Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 12:309-311 (Pubitemid 351853463)
-
(2008)
Journal of AAPOS
, vol.12
, Issue.3
, pp. 309-311
-
-
Cakir, M.1
Cekic, O.2
Yilmaz, O.F.3
-
9
-
-
69449102693
-
Coats' disease: Treatment with intravitreal bevacizumab and laser photocoagulation
-
Stergiou PK, Symeonidis C, Dimitrakos SA (2009) Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation. Acta Ophthalmol 87:687-688
-
(2009)
Acta Ophthalmol
, vol.87
, pp. 687-688
-
-
Stergiou, P.K.1
Symeonidis, C.2
Dimitrakos, S.A.3
-
10
-
-
42049110754
-
Management of Coats disease with bevacizumab in 2 patients
-
DOI 10.3129/I08-028
-
Venkatesh P, Mandal S, Garg S (2008) Management of Coats' disease with bevacizumab in 2 patients. Can J Ophthalmol 43:245-246 (Pubitemid 351518186)
-
(2008)
Canadian Journal of Ophthalmology
, vol.43
, Issue.2
, pp. 245-246
-
-
Venkatesh, P.1
Mandal, S.2
Garg, S.3
-
11
-
-
77951173410
-
The effect of intravitreal bevacizumab in the treatment of Coats disease in children
-
Lin CJ, Hwang JF, Chen YT, Chen SN (2010) The effect of intravitreal bevacizumab in the treatment of Coats disease in children. Retina 30:617-622
-
(2010)
Retina
, vol.30
, pp. 617-622
-
-
Lin, C.J.1
Hwang, J.F.2
Chen, Y.T.3
Chen, S.N.4
-
12
-
-
77649206199
-
Combined intravitreal bevacizumab and argon laser treatment for Coats' disease
-
Cackett P, Wong D, Cheung CM (2010) Combined intravitreal bevacizumab and argon laser treatment for Coats' disease. Acta Ophthalmol 88:e48-e49
-
(2010)
Acta Ophthalmol
, vol.88
-
-
Cackett, P.1
Wong, D.2
Cheung, C.M.3
-
13
-
-
73849109765
-
Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children
-
Kaul S, Uparkar M, Mody K, Walinjkar J, Kothari M, Natarajan S (2010) Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children. Indian J Ophthalmol 58:76-78
-
(2010)
Indian J Ophthalmol
, vol.58
, pp. 76-78
-
-
Kaul, S.1
Uparkar, M.2
Mody, K.3
Walinjkar, J.4
Kothari, M.5
Natarajan, S.6
-
15
-
-
56049093465
-
Resolution of severe macular edema in adult Coats' disease with intravitreal triamcinolone and bevacizumab injection
-
Jun JH, Kim YC, Kim KS (2008) Resolution of severe macular edema in adult Coats' disease with intravitreal triamcinolone and bevacizumab injection. Korean J Ophthalmol 22:190-193
-
(2008)
Korean J Ophthalmol
, vol.22
, pp. 190-193
-
-
Jun, J.H.1
Kim, Y.C.2
Kim, K.S.3
-
16
-
-
77949650900
-
Coats' disease: An Indian perspective
-
Rishi P, Rishi E, Uparkar M, Sharma T, Gopal L, Bhende P, Bhende M, Sen PR, Sen P (2010) Coats' disease: an Indian perspective. Indian J Ophthalmol 58:119-124
-
(2010)
Indian J Ophthalmol
, vol.58
, pp. 119-124
-
-
Rishi, P.1
Rishi, E.2
Uparkar, M.3
Sharma, T.4
Gopal, L.5
Bhende, P.6
Bhende, M.7
Sen, P.R.8
Sen, P.9
-
17
-
-
34548022138
-
Elevated vascular endothelial growth factor levels in Coats disease: Rapid response to pegaptanib sodium
-
DOI 10.1007/s00417-007-0559-8
-
Sun Y, Jain A, Moshfeghin DM (2007) Elevated vascular endothelial growth factor levels in Coats disease: rapid response to pegaptanib sodium. Graefe's Arch Clin Exp Ophthalmol 245:1387-1388 (Pubitemid 47278676)
-
(2007)
Graefe's Archive for Clinical and Experimental Ophthalmology
, vol.245
, Issue.9
, pp. 1387-1388
-
-
Sun, Y.1
Jain, A.2
Moshfeghi, D.M.3
-
18
-
-
77956189058
-
Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab
-
He YG, Wang H, Zhao B, Lee J, Bahl D, McCluskey J (2010) Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab. Graefes Arch Clin Exp Ophthalmol 248(10): 1519-1521
-
(2010)
Graefes Arch Clin Exp Ophthalmol
, vol.248
, Issue.10
, pp. 1519-1521
-
-
He, Y.G.1
Wang, H.2
Zhao, B.3
Lee, J.4
Bahl, D.5
McCluskey, J.6
-
19
-
-
52949113486
-
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
-
Tübingen Bevacizumab Study Group
-
Zhu Q, Ziemssen F, Henke-Fahle S, Tatar O, Szurman P, Aisenbrey S, Schneiderhan-Marra N, Xu X, Tübingen Bevacizumab Study Group, Grisanti S (2008) Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization. Ophthalmology 115:1750-1755
-
(2008)
Ophthalmology
, vol.115
, pp. 1750-1755
-
-
Zhu, Q.1
Ziemssen, F.2
Henke-Fahle, S.3
Tatar, O.4
Szurman, P.5
Aisenbrey, S.6
Schneiderhan-Marra, N.7
Xu, X.8
Grisanti, S.9
|